A semi-supervised deep learning and IoMT framework for robust prostate cancer grading under imperfect histopathology data conditions
Computer Methods and Programs in Biomedicine · 2026-10 · 285 · 109527
DOI: 10.1016/j.cmpb.2026.109527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computer Methods and Programs in Biomedicine, 2026-10. Verfasst von Imran Ahmed und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Computing and Information Science, Anglia Ruskin University, East Road, Cambridge, CB1 1PT, United Kingdom. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Deep Learning, Supervised Machine Learning. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Technology Development.
Abstract (Originalsprache)
Deep learning has shown remarkable promise in histopathological cancer diagnostics; however, its performance heavily depends on the availability of large-scale, high-quality labelled data, which is often an unrealistic assumption in clinical practice. To address the challenges posed by imperfect and limited data, this paper presents a semi-supervised learning (SSL)- driven Internet of Medical Things (IoMT) framework for automated prostate cancer grading using whole-slide histopathology images. The proposed framework integrates deep learning, IoMT data acquisition, and cloud inference to deliver scalable, resource-efficient diagnostics. The framework employs a modified YOLOv11 architecture for region detection and classification, incorporating preprocessing techniques, patch-wise analysis, and mask-based region-of-interest extraction to convert raw biopsy data into structured, clinically relevant Gleason grade predictions (benign, a=Grade 3, 4, or 5). The IoT-enabled imaging devices might support real-time data capture and edge-level preprocessing, while the cloud component facilitates resource efficiency and centralised model inference. This dual-layer framework is designed to support flexible deployment for both on-site diagnostics and remote telepathology workflows, making it highly applicable in under-resourced settings. The framework also incorporates explainability through Grad-CAM to enhance interpretability and clinical trust. Experimental results on the PANDA dataset demonstrate strong diagnostic performance, achieving 81.2% accuracy, an F1-score of 0.68, mAP@0.5 of 0.64, and an average IoU of 0.58. The results suggest that the proposed semi-supervised framework can support prostate cancer grading under imperfect data conditions, while the IoMT architecture provides a basis for future deployment in connected digital pathology workflows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Computing and Information Science, Anglia Ruskin University, East Road, Cambridge, CB1 1PT, United Kingdom.
- Department of Embedded Systems Engineering, Incheon National University, 119 Academy-ro, Yeonsu-gu, Incheon, 22012, South Korea. Electronic address: gjeon@inu.ac.kr.
Förderung
- Technology Development
Zitieren
APA
Ahmed, I., Zhang, J., Cirstea, S., & Jeon, G. (2026). A semi-supervised deep learning and IoMT framework for robust prostate cancer grading under imperfect histopathology data conditions. Computer Methods and Programs in Biomedicine, 285, 109527. https://doi.org/10.1016/j.cmpb.2026.109527
Vancouver
Ahmed I, Zhang J, Cirstea S, Jeon G. A semi-supervised deep learning and IoMT framework for robust prostate cancer grading under imperfect histopathology data conditions. Computer Methods and Programs in Biomedicine. 2026;285:109527. doi:10.1016/j.cmpb.2026.109527
BibTeX
@article{Ahmed2026,
author = {Ahmed, Imran and Zhang, Jin and Cirstea, Silvia and Jeon, Gwanggil},
title = {A semi-supervised deep learning and IoMT framework for robust prostate cancer grading under imperfect histopathology data conditions},
journal = {Computer Methods and Programs in Biomedicine},
year = {2026},
volume = {285},
pages = {109527},
doi = {10.1016/j.cmpb.2026.109527}
}
EUVIMED